Cargando…
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
Pancreatic ductal adenocarcinoma (PDAC) is responsible for 7.3% of all cancer deaths. Even though there is a steady increase in patient survival for most cancers over the decades, the patient survival rate for pancreatic cancer remains low with current therapeutic strategies. The Wnt/β-catenin pathw...
Autores principales: | Ram Makena, Monish, Gatla, Himavanth, Verlekar, Dattesh, Sukhavasi, Sahithi, K. Pandey, Manoj, C. Pramanik, Kartick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747343/ https://www.ncbi.nlm.nih.gov/pubmed/31480221 http://dx.doi.org/10.3390/ijms20174242 |
Ejemplares similares
-
Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
por: Gatla, Himavanth Reddy, et al.
Publicado: (2019) -
Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer
por: Pramanik, Kartick C., et al.
Publicado: (2018) -
Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors
por: Yavvari, Siddhartha, et al.
Publicado: (2019) -
Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach
por: Hussain, Naushair, et al.
Publicado: (2022) -
MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma
por: Wei, Sung-Jen, et al.
Publicado: (2020)